These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26782435)

  • 1. Elevated expression of CXCR4 and correlation with clinicopathological features and prognosis of non-small cell lung cancer patients: a meta-analysis.
    Wang H; Xie F; Hu Z; Chen L
    Genet Mol Res; 2015 Dec; 14(4):17893-903. PubMed ID: 26782435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A meta-analysis for CXCR4 as a prognostic marker and potential drug target in non-small cell lung cancer.
    Zhang C; Li J; Han Y; Jiang J
    Drug Des Devel Ther; 2015; 9():3267-78. PubMed ID: 26150700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant overexpression of EGFR and CXCR4 is associated with worse prognosis in a new molecular subtype of non-small cell lung cancer.
    Al Zobair AA; Al Obeidy BF; Yang L; Yang C; Hui Y; Yu H; Zheng F; Yang G; Xie C; Zhou F; Zhou Y
    Oncol Rep; 2013 Apr; 29(4):1524-32. PubMed ID: 23443279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of miR-503 expression predicate advanced mythological features and poor prognosis in patients with NSCLC.
    Liu L; Qu W; Zhong Z
    Int J Clin Exp Pathol; 2015; 8(5):5609-13. PubMed ID: 26191272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
    Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
    BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survivin protein expression is involved in the progression of non-small cell lung cancer in Asians: a meta-analysis.
    Duan L; Hu X; Jin Y; Liu R; You Q
    BMC Cancer; 2016 Apr; 16():276. PubMed ID: 27090386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of CXCR4 expression with prognosis and clinicopathological indicators in colorectal carcinoma patients: a meta-analysis.
    Lv S; Yang Y; Kwon S; Han M; Zhao F; Kang H; Dai C; Wang R
    Histopathology; 2014 Apr; 64(5):701-12. PubMed ID: 24422942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
    Liu X; Huang G; Zhang J; Zhang L; Liang Z
    PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CXCR4 and VEGF-C is correlated with lymph node metastasis in non-small cell lung cancer.
    Bi MM; Shang B; Wang Z; Chen G
    Thorac Cancer; 2017 Nov; 8(6):634-641. PubMed ID: 28925100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexpression of CXCR4 and MMP9 predicts lung metastasis and poor prognosis in resected osteosarcoma.
    Ren Z; Liang S; Yang J; Han X; Shan L; Wang B; Mu T; Zhang Y; Yang X; Xiong S; Wang G
    Tumour Biol; 2016 Apr; 37(4):5089-96. PubMed ID: 26546437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression and significance of tumor associated macrophages and CXCR4 in non-small cell lung cancer.
    Yusen W; Xia W; Shengjun Y; Shaohui Z; Hongzhen Z
    J BUON; 2018; 23(2):398-402. PubMed ID: 29745083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CXCR4 and Nrf2 expressions in non-small cell lung cancer and their clinical implications].
    Hu T; Yao Y; Yu S; Guo H; Tian T; Han L; Wang W; Guo Q; Wang J; Nan K; Wang S
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Feb; 34(2):153-8. PubMed ID: 24589587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and clinical evidence of miR-494 and PTEN in non-small cell lung cancer.
    Wang J; Chen H; Liao Y; Chen N; Liu T; Zhang H; Zhang H
    Tumour Biol; 2015 Sep; 36(9):6965-72. PubMed ID: 25861022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased osteopontin protein expression may be correlated with poor prognosis in non-small-cell lung cancer: A meta analysis.
    Shi SM; Su ZB; Zhao JJ; Yu DJ; Tu JW; Zhu JQ; Zhao JP; Sheng L; Wang SB; Sheng YJ; Chen HJ; Tian JH; Zhang Y; Wang J
    J Cancer Res Ther; 2016; 12(1):277-82. PubMed ID: 27072251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of angiopoietin-2 in non-small cell lung cancer patients: a meta-analysis.
    Xuan ZX; Zhang S; Yuan SJ; Wang W; Yu J
    World J Surg Oncol; 2016 Sep; 14(1):237. PubMed ID: 27589869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological significance of CXCR4 in non-small cell lung cancer.
    Zhou XM; He L; Hou G; Jiang B; Wang YH; Zhao L
    Drug Des Devel Ther; 2015; 9():1349-58. PubMed ID: 25834393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-resistant CXCR4-positive cells have the molecular characteristics of EMT in NSCLC.
    Yin H; Wang Y; Chen W; Zhong S; Liu Z; Zhao J
    Gene; 2016 Dec; 594(1):23-29. PubMed ID: 27581786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
    Yang J; Liu H; Wang H; Sun Y
    Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DAPK promoter methylation status correlates with tumor metastasis and poor prognosis in patients with non-small cell lung cancer.
    Zhang J; Yu XL; Zheng GF; Zhao F
    Cancer Biomark; 2015; 15(5):609-17. PubMed ID: 26406950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinicopathological and prognostic value of CXCR4 expression in patients with lung cancer: a meta-analysis.
    Qiu L; Xu Y; Xu H; Yu B
    BMC Cancer; 2022 Jun; 22(1):681. PubMed ID: 35729596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.